No Detail Found!

Cancer-Testis Antigen Colorectal Cancer Patients

Author(s)
Noor Akeel Hameed Sheikh Zayed Hospital, Baghdad, Al-Rusafa Health Directorate, Ministry of Health, Iraq
Ahmed Rushdi Abdullah Department of Microbiology, Medical College, Al-Iraqia University, Baghdad, Iraq
Abstract
Background: Colorectal cancer is a leading cause of cancer-related mortality worldwide. Early detection is essential for effective treatment. Cancer-testis antigens, such as MAGE-A3, have been identified as potential biomarkers in cancer progression and therapy. This study aimed to evaluate the mRNA expression of MAGE-A3 in blood samples from patients with colorectal cancer (CRC) and non-malignant colorectal diseases (CRD). Methods: A total of 60 patients (30 CRC, 30 CRD) and 30 healthy controls were included. Ages (16-81), whose samples were collected from the Medical City Directory hospitals (GIT and Liver diseases Teaching hospital, Baghdad Teaching Hospital and Oncology Hospital) from 1st of November 2024 to 31 January 2025. and RNA was extracted using TRIzol™ reagent. Quantitative PCR (qPCR) was used to measure MAGE-A3 expression, normalised for the healthy control group. Statistical comparisons were made between CRC and CRD groups. The proportion of patients exhibiting gene expression levels above one is elevated in CRC. Results: sex distribution was not statistically significant (p>0.05), adenocarcinoma was the dominant type of cancer among such cases, a subgroup of patients (86.7%), The grade was moderately differentiated among the majority of patients (83.3%), MAGE-A3 mRNA expression was higher in CRC than CRD (52.6% vs. 47.4%; Likelihood Ratio = 4.317, df = 1, p = 0.038). Conclusion: MAGE-A3 mRNA expression is markedly elevated in CRC and may serve as a potential diagnostic biomarker for distinguishing malignant from benign colorectal conditions.
Publication Details
Page(s) 145-150
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 2, Year: 2026

Request the full text from PASTIC

Keywords
colorectal cancer, in, Cancer-Testis Antigens, gene expression, MAGE-A3, Colorectal Diseases, Expression
References
Weledji E.P. “ .2024 .The Aetiology and Pathogenesis of Colorectal Cancer. Clin Oncol, 9 : 2474.
Roshandel G.,Cancers G.,January G. .2024 .Colorectal Cancer: Epidemiology, Risk Factors and Prevention. , 16(8) : .
Cao Q.,Implications Prognostic,March Prognostic .2024 .Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic. International Journal of Molecular Sciences, 25(6) : .
Ibrahem S. .2022 .Trends in Colorectal Cancer in Iraq over Two Decades: Incidence, Mortality, Topography. ” Annals of Saudi Medicine, 252(4) : 0256-4947.
Weon J.L.,Potts P.R. .2015 .. The MAGE Protein Family and Cancer.” Current Opinion in Cell Biology, 08 : 1-8.
Khalvandi A. . .Nuclear Overexpression Levels of MAGE-A3 Predict Poor Prognosis in Patients with Prostate Cancer. ” APMIS, 129(6) : 291-303.
Su J.,April J. .2025 .Unveiling MAGEA3: A Novel Predictive Biomarker for Bevacizumab Resistance in Colorectal Cancer. Cancer Drug Resistance, 35 : .
Alves P.M.S. . .Molecular and Immunological Evaluation of the Expression of Cancer/Testis Gene Products in Human Colorectal Cancer. Cancer Immunology, Immunotherapy, 56(6) : 839-847.
Pineda C.T. .2015 .Degradation of AMPK by a CancerSpecific Ubiquitin Ligase. ” Cell, 01(4) : 715-728.
Szincsak S.,Meta-Analysis S. .2025 .Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review. International Journal of Molecular Sciences, 26(13) : .
Livak T.D.,Schmittgen T.D.,Method ΔΔCT .2001 .Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2. ” Methods, 1262(2001) : 402-408.
Vafaei S. .2019 .Common Molecular Markers between Circulating Tumor Cells and Blood Exosomes in Colorectal Cancer: A Systematic and Analytical Review. Cancer Management and Research, 11 : 8669-8698.
Shin K.C. .2011 .MAGE A1-A6 RT-PCR and MAGE A3 and p16 Methylation Analysis in Induced Sputum from Patients with Lung Cancer and Non-Malignant Lung Diseases. Oncology Reports, 1566(2012) : 911-916.
Ries J. .2012 .Grade of Dysplasia for Predicting Malignant Progression of Oral Leukoplakia. International Journal of Oncology, 1532(2012) : 1085-1093.
Bhutani M. .2010 .Frequent Expression of MAGE1 Tumor Antigens in Bronchial Epithelium of Smokers without Lung Cancer.” Experimental and Therapeutic Medicine. , 176(2010) : 137-142.
Hudolin T. . .Immunohistochemical Expression of Tumor Antigens MAGE-A1, MAGE-A3/4 and NY-ESO-1 in Cancerous and Benign Prostatic Tissue. ” Prostate, 66(2006) : 13-18.
Kumara Shantha,H.M.C. Shantha .12 .MAGE-A3 Is Highly Expressed in a Subset of Colorectal Cancer Patients. ” Cancer Immunology, 16 : 1424-9634.
Mori M. . .Expression of MAGE Genes in Human Colorectal Carcinoma. ” Annals of Surgery, 224(1996) : 8000-00011.
Gonzalez R.,PD-L1 Protein Show Bladder,Cancer Bladder .2024 .Abstract 2513: MAGE-A3, MAGE-A4 and. 6 Suppl, 2513 : AM2024-7445.
Koyanagi K. .2008 .Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial. ” Clinical Cancer Research, 08(22) : 1078-0432.
Batchu R.B. .2009 .B Cell Transduction of Capsid Mutant (Y730F) Adeno-Associated Virus-2 Vectors with MAGE-A3 Gene for Immunotherapy of Colorectal Cancer. , 11 : .
Almutairi M.H. .2022 .Identification of MAGE-A Family Genes in Colon Cancer Patients and Their Expression Mechanism. ” Journal of King, 102251(7) : .
Han A .2024 .Abstract 2746: MAGE-A3 Co-Expression with IDH1-R132H and IL-1β in Colon Cancer. 6 Suppl, 2746 : AM2024-7445.
0

Citations

0

Downloads

15

Views